David Zweig, published author and science journalist based in New York, joins the show to tackle one specific topic pertaining to the COVID-19 pandemic: mask mandates for children in schools. David’s article “The CDC’s Flawed Case for Wearing Masks in School” was published in The Atlantic early this month and spotlights the “very shaky science” propped up by the CDC that has compelled many schools throughout the US to institute mask mandates for their students. Chadi and David analyze the data—fleshing out all of the details and scenarios—of mask-wearing in schools in this fiery, no-holds-barred discussion that will surely ruffle some feathers.
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
